uniQure (QURE) Retained Earnings (2015 - 2026)
uniQure's (QURE) quarterly Retained Earnings came in at -$1.4 billion in Q1 2026, down 2469.41% year-on-year from $58.3 million in Q1 2025, and down 2274.48% quarter-over-quarter from -$58.2 million in Q4 2025.
uniQure (QURE) Retained Earnings (2015 - 2026) Analysis & Trends
uniQure's Retained Earnings history runs 12 years deep, the most recent figure standing at -$1.4 billion for Q1 2026.
- On a quarterly basis, Retained Earnings fell 2469.41% year-over-year to -$1.4 billion in Q1 2026; TTM through Mar 2026 was -$1.4 billion, a 2469.41% decrease from a year earlier, with the FY2025 full-year figure at -$58.2 million, up 94.85% from the prior year.
- Retained Earnings declined to -$1.4 billion in Q1 2026 per QURE's latest filing, from -$58.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.3 billion in Q2 2025 and bottomed at -$1.4 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$58.3 million (2022), against an average of -$265.4 million.
- Across the five-year window, Retained Earnings surged 259.81% in 2024 and slumped 2469.41% in 2026, its largest moves.
- Year by year, Retained Earnings stood at -$58.3 million in 2022, then gained by 8.06% to -$53.6 million in 2023, then plunged by 2008.14% to -$1.1 billion in 2024, then soared by 94.85% to -$58.2 million in 2025, then plunged by 2274.48% to -$1.4 billion in 2026.
- Per Business Quant, the three latest QURE Retained Earnings figures stand at -$1.4 billion (Q1 2026), -$58.2 million (Q4 2025), and -$1.3 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | -1.38 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.38 Bn |
| Dec 31, 2025 | -58.22 Mn |
| Sep 30, 2025 | -1.29 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | -53.81 Mn |
| Dec 31, 2024 | -1.13 Bn |
| Sep 30, 2024 | -1.06 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | -56.04 Mn |
| Dec 31, 2023 | -53.60 Mn |
| Sep 30, 2023 | -817.20 Mn |
| Jun 30, 2023 | -727.63 Mn |
| Mar 31, 2023 | -52.49 Mn |
| Dec 31, 2022 | -58.30 Mn |
| Sep 30, 2022 | -93.00 Mn |
| Jun 30, 2022 | -67.63 Mn |
| Mar 31, 2022 | -39.31 Mn |
| Dec 31, 2021 | -28.90 Mn |
| Sep 30, 2021 | 1.07 Bn |
| Jun 30, 2021 | 1.06 Bn |